Journal
INTERNATIONAL JOURNAL OF STD & AIDS
Volume 26, Issue 11, Pages 803-809Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0956462414553826
Keywords
HIV; HAART; Asia; AIDS; treatment; antiretroviral therapy; immunological response; CD4 count
Categories
Funding
- Medical Faculty, The Chinese University of Hong Kong [4054074]
- Health and Medical Research Fund of Food and Health Bureau of the Hong Kong Special Administrative Region Government [CU-14-03-01]
- Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong
Ask authors/readers for more resources
To explore the heterogeneity of CD4 responses following highly active antiretroviral therapy, the patterns of CD4 recovery of HIV-1-infected Chinese patients who have been on their first antiretroviral regimen for >= 5 years were analysed. The CD4 trajectories were traced, smoothed and differentiated into three defined profiles. Half (56.3%) were 'satisfactory responders', with CD4 gain of > 100 cells/mu L and a peak of > 350 cells/mL, plateauing before the end of Year 5. Thirty-three (24.4%) were 'continuing responders' whose CD4 rise persisted at Year 4-5. The remaining 26 (19.3%) were 'poor responders'. Presentation with AIDS before therapy was common not just among 'poor' but also paradoxically the 'continuing' responders. While a majority had responded well to antiretroviral therapy, older patients and those with AIDS diagnosis before initiation of therapy may never achieve a satisfactory level even with effective treatment. Categorization of HIV patients by their CD4 trajectory may support the prediction of immunological outcome over time, and ultimately inform treatment choices.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available